s6y

3 ALNYLAM PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001735276-19-000089

Documents

  1. PRIMARY DOCUMENT 3
  2. EDGAR SUPPORTING DOCUMENT EX-24

On sec.gov